Generieke Naam
|
Handelsmerknaam/
Alternatiewe Naam
|
Uitdruksstelsel
|
Aanwysings
|
Vervaardiger
|
Laaste stadium
|
PTH 1-34
|
hPTH-1-34, LY 333334, MN-10, Forteo, Forsteo、复泰奥, フォルテオ
|
Escherichia coli (E. coli)
|
Osteoporose, Manlike osteoporose, Postmenopausale osteoporose, Glukokortikoïd-geïnduceerde osteoporose
|
Eli Lilly
|
Goedkeuring
|
PTH 1-34
|
Ostiogen, 珍固
|
E. coli
|
Postmenopausale osteoporose
|
Shanghai United Cell Biotechnology
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
SAL001, 欣复泰
|
E. coli
|
Postmenopausale osteoporose
|
SALUBRIS
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Postmenopausale osteoporose
|
Teva Pharms
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Pfenex, PF-708, Bonsity, Qutavina
|
Pseudomonas fluorescens
|
Postmenopausale osteoporose
|
Pfenex, Alvogen, Eurogenerics
|
Goedkeuring
|
PTH 1-34
|
Kauliv
|
E. coli
|
Napostmenopausale osteoporose, Manlike osteoporose, Glukokortikoïed-geïnduceerde osteoporose
|
Strides Pharma Science Limited
|
Goedkeuring
|
PTH 1-34
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Enzene Biosciences
|
Goedkeuring
|
PTH 1-34
|
Sondelbay
|
E. coli
|
Napostmenopausale osteoporose, Manlike osteoporose, Glukokortikoïed-geïnduceerde osteoporose
|
Accord Healthcare
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Movymia, rhPTH (1-34)
|
E. coli
|
Osteoporose
|
STADA Arzneimittel AG
|
Goedkeuring
|
PTH 1-34 -RGB10
|
Terrosa,テリパラチド, RGB-10
|
E. coli
|
Postmenopausale osteoporose, Manlike osteoporose, Osteoporose
|
Gedeon Richter, Mochida Pharmaceutical
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Bonista, Osteotide, rhPTH (1-34)
|
NA, Sintetiese peptid
|
Osteoporose, Postmenopausale osteoporose
|
Sun Pharmaceutical Industries Ltd.
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Livogiva
|
Pseudomonas fluorescens
|
Osteoporose, Postmenopausale osteoporose
|
Theramex Ireland Limited
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
rhPTH (1-34)
|
Wag opdate
|
Osteoporose, Postmenopausale osteoporose
|
Zydus Lifesciences Ltd.
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Osteofortil, rhPTH (1-34)
|
Wag opdate
|
Osteoporose, Postmenopausale osteoporose
|
Biosidus SA
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Terifrac, INTG8
|
Wag opdate
|
Osteoporose, Postmenopausale osteoporose
|
Intas Biopharmaceuticals Ltd
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Osteoporose, Postmenopausale osteoporose
|
USV Pvt Ltd., Union Square Ventures LLC
|
Goedkeuring
|
PTH 1-34 biogegeweek
|
rhPTH (1-34)
|
Wag opdate
|
Osteoporose, Postmenopausale osteoporose
|
AMEGA Biotech
|
Goedkeuring
|
PTH 1-34 Acetate
|
eenmaal per week MN-10-T, Teribone, テリボン
|
NE, Chemiese sintese
|
Osteoporose
|
Asahi Kasei Pharma
|
Goedkeuring
|
Abaloparatide
|
TYMLOS
|
NE, Chemiese sintese
|
Osteoporose
|
Ipsen, Radius Health, TEIJIN-groep
|
Goedkeuring
|
PTH 1-34
|
HB1082
|
Wag opdate
|
Osteoporose
|
Wuxi Hebang Biotechnology
|
Indien vir goedkeuring
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Beijing Genetech Pharmaceutical
|
Indien vir goedkeuring
|
PTH 1-34, eenmaal per week
|
SAL056
|
Wag opdate
|
Osteoporose
|
SALUBRIS
|
Fase III
|
PTH 1-34 biogegeweek
|
rhPTH (1-34)
|
Wag opdate
|
Osteoporose Postmenopausale osteoporose
|
Shanghai United Cell Biotechnology
|
Fase III
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Osteoporose Postmenopausale osteoporose
|
Wêreldwye chemikalië, Great Bay Bio
|
Fase III
|
PTH 1-34 biogegeweek
|
rhPTH (1-34)
|
Wag opdate
|
DiGeorge-sindroom Hipo-tiroïedism
|
Nasionale Instituut vir Tand- en Kraniumgesigsonderzoek
|
Fase III
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Postmenopausale osteoporose
|
Zhongke Shenglongda Biotechnologie
|
Fase III
|
PTH 1-34
|
EB613
|
Wag opdate
|
Osteoporose
|
Entera Bio
|
Fase II
|
PTH 1-34
|
EB612
|
Wag opdate
|
Hipoparatiroidisme
|
Entera Bio
|
Fase II
|
PTH 1-34 transdermaal
|
hPTH(1-34), MicroCor PTH, PTH 1-34 transdermaal
|
Wag opdate
|
Osteoporose
|
Corium International, Inc.
|
Fase II
|
PTH 1-34 mikroneel-ZP-PTH
|
Mikro-naald transdermale leweringsisteen
|
Wag opdate
|
Osteoporose
|
Zosano Pharma, Asahi Kasei
|
Fase II
|
PTH 1-34 biogegeweek
|
AK159
|
Wag opdate
|
Osteoporose
|
Asahi Kasei Pharma Corp.
|
Fase I
|
PTH 1-34 biogegeweek
|
SBL-001
|
Wag opdate
|
Osteoporose
|
Stelis Biopharma Pvt Ltd.
|
Fase I
|
PTH 1-34 biogegeweek
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Critical Pharmaceuticals Ltd.
|
Fase I
|
PTH 1-34 biogegeweek
|
T0003
|
Wag opdate
|
Osteoporose
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Pharmaceuticals
|
Fase I
|
PTH 1-34 -Bonosome
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Minapharm Pharmaceuticals
|
Fase I
|
PTH 1-34 -PB (Osteo)-1010
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Paras Biopharmaceuticals Finland
|
Voor-klinies
|
Paratiroïedhormoon (PTH) fusionspolipeptide
|
lange werkende PTH 1-34, AEZS-150, DC-PTH
|
Wag opdate
|
Hipoparatiroidisme
|
Aeterna Zentaris
|
Voor-klinies
|
KUR 111
|
I-0401, KUR 111
|
Wag opdate
|
Breek
|
Kuros Biosciences Ltd.
|
Fase II
|
Fibrin-PTH
|
I-040202, KUR 113
|
Wag opdate
|
Degenerasie van intervertebrale skyf Breek
|
Kuros Biosciences Ltd.
|
Fase II
|
paratiroidhormoon 1-34
|
Wag opdate
|
Wag opdate
|
Osteoporose
|
Celgen biopharma
|
Fase II
|
Paratiroidhormoon 1-34
|
Mondbare kapsule, RT102, RT110
|
Wag opdate
|
Osteoporose
|
Rani Therapeutics LLC
|
Fase I
|
PTH-CBD
|
BMD 1221
|
Wag opdate
|
Fraktuur / Haar groei
|
BiologicsMD, Universiteit van Arkansas-stelsel
|
Voor-klinies
|
PTH-1A
|
Paratiroidhormoon Inverse Agonist
|
Wag opdate
|
Metaphysele chondrodysplasie, Jansen tipe
|
Nasionale Instituuts vir Gesondheid
|
Voor-klinies
|
Paratiroidhormoon-PLX-PTH
|
PTH (1-34), hidrogel aminomikrosfere
|
Wag opdate
|
Hipoparatiroidisme
|
ProLynx
|
Voor-klinies
|
Abaloparatide-BA-O58
|
BA-O58
|
NA, Sintetiese peptid
|
Postmenopausale osteoporose
|
Enzene Biosciences
|
Voor-klinies
|
Paratiroidhormoon
|
rhPTH(1-84), NPSP-558, SHP-635, SHP-634, NPSP-795, ALX-111, SB-423562, Natpara, Preotact, Natpar
|
E. coli
|
Hypokalsemie, Hypoparatiroidisme
|
Takeda, Shire Plc
|
Goedkeuring
|
Paratiroidhormoon 1-84
|
rhPTH (1-84)
|
Wag opdate
|
Osteoporose Postmenopausale osteoporose
|
Kerun biopharm
|
Fase III
|
Paratiroidhormoon 1-84
|
Wag opdate
|
Wag opdate
|
Hypokalsemie
|
Buchang pharma
|
Fase I
|
ACP-014
|
PTH prodrug, TransCon PTH, Yorvipath
|
Wag opdate
|
Hipoparatiroidisme
|
Ascendis Pharma A/S, VISEN Pharmaceuticals
|
Goedkeuring
|
Paratiroidhormoon verwante proteïen (1-36)
|
1-36 menslike PTHRP, 1-36 menslike humoral hiperkalsemiese faktor, HUMAN PTHRP-(1-36)
|
Wag opdate
|
Osteoporose
|
Nasionale Instituuts vir Gesondheid
|
Fase II
|
NOV004
|
Wag opdate
|
Wag opdate
|
Onvolkome osteogenesis
|
Novosteo, Quince Therapeutics
|
Voor-klinies
|